Document is current
Any future updates will be listed below
-
Authors
Lim, Sean H. https://orcid.org/0000-0002-2768-4858
Stuart, Beth
Joseph-Pietras, Debora
Johnson, Marina
Campbell, Nicola
Kelly, Adam
Jeffrey, Danielle https://orcid.org/0000-0003-3193-3420
Turaj, Anna H.
Rolfvondenbaumen, Kate
Galloway, Celine
Wynn, Thomas
Coleman, Adam R.
Ward, Benjamin
Long, Karen
Coleman, Helen
Mundy, Carina
Bates, Andrew T.
Ayres, Diana
Lown, Robert
Falconer, Janlyn
Brake, Oliver
Batchelor, James https://orcid.org/0000-0002-5307-552X
Willimott, Victoria
Bowzyk Al-Naeeb, Anna
Robinson, Lisa
O’Callaghan, Ann
Collins, Graham P.
Menne, Tobias
Faust, Saul N.
Fox, Christopher P.
Ahearne, Matthew
Johnson, Peter W. M.
Davies, Andrew J.
Goldblatt, David
-
Funding
Funding for this research was provided by:
Cancer Research UK (A27179, a25141)
Blood Cancer UK Vaccine Research Collaborative
- License Information
-
More Information
Article History
Received: 2 December 2021
Accepted: 10 March 2022
First Online: 24 March 2022
Competing interests
: S.H.L., N.C., M.J., D.J.P., A.O., H.C., C.M., A.K., A.R.C., A.H.T., K.L., D.J., B.W., T.W., A.T.B., K.R., B.S., C.G., D.A., J.F., O.B., J.B., V.M., A.B.A.-N., L.R., T.M., P.W.M.J. and D.G. declare no competing interests. C.F. receives consultancy fees from AstraZeneca and participates in an advisory board for AstraZeneca. M.A. receives research funding from Pfizer. G.P.C. receives research funding from Pfizer and participates in advisory boards for AstraZeneca and Pfizer. R.L. reports receiving speaker fees and honoraria from Janssen. A.J.D. reports receiving research funding and honoraria from AstraZeneca and Janssen. S.N.F. participates in advisory boards related to vaccines or grants for contract commercial clinical trials that were paid to S.N.F.’s institution (with no personal payment of any kind) from AstraZeneca/Medimmune, Sanofi, Pfizer, Seqirus, Merck, GSK, J&J, Merck and Valneva, outside the submitted work.
